Mutual of America Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $75.4K | Sell |
|
|||||
|
2025
Q2 | $62.9K | Sell |
|
|||||
|
2025
Q1 | $118K | Sell |
|
|||||
|
2024
Q4 | $189K | Buy |
|
|||||
|
2024
Q3 | $374K | Sell |
|
|||||
|
2024
Q2 | $364K | Sell |
|
|||||
|
2024
Q1 | $325K | Sell |
|
|||||
|
2023
Q4 | $297K | Buy |
|
|||||
|
2023
Q3 | $230K | Sell |
|
|||||
|
2023
Q2 | $369K | Sell |
|
|||||
|
2023
Q1 | $388K | Sell |
|
|||||
|
2022
Q4 | $246K | Buy |
|
|||||
|
2022
Q3 | $306K | Buy |
|
|||||
|
2022
Q2 | $245K | Buy |
|
|||||
|
2022
Q1 | $290K | Buy |
|
|||||
|
2021
Q4 | $301K | Buy |
|
|||||
|
2021
Q3 | $336K | Sell |
|
|||||
|
2021
Q2 | $335K | Buy |
|
|||||
|
2021
Q1 | $306K | Buy |
|
|||||
|
2020
Q4 | $186K | Buy |
|
|||||
|
2020
Q3 | $117K | Buy |
|
|||||
|
2020
Q2 | $41K | Buy |
|
|||||
|
2020
Q1 | $47K | Buy |
|
|||||
|
2019
Q4 | $72K | Sell |
|
|||||
|
2019
Q3 | $80K | Buy |
|
|||||
|
2019
Q2 | $73K | Buy |
|
|||||
|
2019
Q1 | $70K | Buy |
|
|||||
|
2018
Q4 | $53K | Buy |
|
|||||
|
2018
Q3 | $62K | Buy |
|
|||||
|
2018
Q2 | $10K | Buy |
|